Finally, patients who developed septic shock showed altered immune status compared to patients who did not develop septic shock, with sustained low HLA-DR/monocytes from D2 to D28 and high serum levels of IL-6, IL-10, and IL-17 at late time points (Figure 4B). The gene discussed is IL6; the disease is Shock.